Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-02-13-Speech-2-248"

PredicateValue (sorted: default)
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20010213.10.2-248"2
lpv:hasSubsequent
lpv:speaker
lpv:spokenAs
lpv:translated text
"Mr President, I congratulate Mr Bowe on the report and on the positions assumed which, given the thorny nature of the issue of genetically modified organisms, is genuinely well-balanced. What is the conclusion? The conclusion is that rules and monitoring are necessary. I am sure that we will be able to find some point of contention – for example, the issues of traceability and labelling remain unresolved – but given the crucial need for regulation, I feel that this task has been more than adequately performed. It must also be remembered that there are many things at stake in this complex matter of genetically modified organisms: it could even be said that, from many points of view, the role of the European Union itself is at stake with regard to many of its forthcoming commitments, such as the World Trade Organisation reforms, the research programme we are about to launch, the development and employment programmes, the relations which will ensue from the creation of new markets, and the globalisation processes which will lead to the redefinition of economic processes. So, as far as GMOs are concerned, we must not forget that the situations in many different countries are different. I would mention, at random, China, South Africa and Mexico, which already grow genetically modified organisms, and other countries such as Cuba which we know are preparing to do so; then there are other countries again, such as Nigeria, Thailand and the Philippines, which are extremely interested in the potential offered by biotechnologies. So the question is this: what role does the Union intend to play in a future which has already become present reality? I feel that the answer which is most relevant to the European Parliament's role can only be to set a course and establish a strategy which reflect a position of total involvement. This does not mean either accepting or rejecting, and still less bringing forward or extending the time frames. Above all, it means giving a sort of green light to all studies, applications or patents relating to biotechnologies. The Bowe report has more than succeeded in achieving this result."@en1

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz
3http://purl.org/linkedpolitics/rdf/spokenAs.ttl.gz

The resource appears as object in 2 triples

Context graph